Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, Foekens JA, Dorssers LC. van Agthoven T, et al. Among authors: brinkman a. Br J Cancer. 2009 Dec 1;101(11):1824-32. doi: 10.1038/sj.bjc.6605423. Epub 2009 Nov 10. Br J Cancer. 2009. PMID: 19904269 Free PMC article.
Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ. Dorssers LC, et al. Among authors: brinkman a. Breast Cancer Res. 2005;7(1):R82-92. doi: 10.1186/bcr954. Epub 2004 Nov 16. Breast Cancer Res. 2005. PMID: 15642172 Free PMC article.
Tamoxifen resistance in breast cancer: elucidating mechanisms.
Dorssers LC, Van der Flier S, Brinkman A, van Agthoven T, Veldscholte J, Berns EM, Klijn JG, Beex LV, Foekens JA. Dorssers LC, et al. Among authors: brinkman a. Drugs. 2001;61(12):1721-33. doi: 10.2165/00003495-200161120-00004. Drugs. 2001. PMID: 11693462 Review.
The prognostic value of BCAR1 in patients with primary breast cancer.
Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, van Broekhoven SP, de Jong D, Peters HA, Portengen H, Meijer-van Gelder ME, Klijn JG, van Tienoven DT, Geurts-Moespot A, Span PN, Foekens JA, Sweep FC. Dorssers LC, et al. Among authors: brinkman a. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6194-202. doi: 10.1158/1078-0432.CCR-04-0444. Clin Cancer Res. 2004. PMID: 15448007
Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, Klijn JG, Geurts-Moespot A, Span PN, Foekens JA, Sweep CG. Dorssers LC, et al. Among authors: brinkman a. Clin Chem. 2004 Aug;50(8):1445-7. doi: 10.1373/clinchem.2004.035493. Epub 2004 May 27. Clin Chem. 2004. PMID: 15166112 Free article. No abstract available.
255 results